Inflammatory enteropathy (IBD) is a group of chronic, non-specific intestinal diseases whose causes are not yet fully defined, mainly including ulcer colonitis (UC) and Crohn ‘ s disease (CD), with many differences in clinical performance, endoscopy, tissue pathology, etc. Accurate identification is essential for the development of treatment programmes and prognosis.
In clinical terms, ulcer enteritis is mainly manifested in chronic or repeated diarrhoea, mucous sepsis, often accompanied by abdominal abdominal pain, mostly in the lower left abdominal or lower abdominal pain, strangulation and a sense of acute ulterior stress. The cronese diarrhea tends to be free of haemorrhage, often in the lower right abdominal or umbilical weeks, with pain of the nature of abdominal pain, swelling or convulsive pain, often accompanied by abdominal parcels, and possibly anal pathologies, such as anal fistula, anal anusesthesia, etc., as a result of dysentery and digestive tracts. For example, a patient who suffers from a long-term recurrence of mucous sepsis and visible pain in the lower left is more inclined to ulcer intestine; if the patient has abdominal pelvis, anal ecstasy and diarrhoea is free of sepsis, he is highly suspected of being Cron disease.
There are significant differences in endoscopy. The increase in ulcer enteritis begins in the rectum and is continuous, permeable, mucous, edema, decomposition and shallow ulcer formation, and mucous vascular texture, disorder or disappearance. The ulcer, pebble and pebble-like appearances can be seen under the Cronian endoscope, where the disease is symmetrically distributed, and the mucous membrane appearances between the intestines are relatively normal, i.e., so-called “jumps”, and can be seen in the narrow intestines, inflammation, etc. In the case of rectal mucous membrane, ulcer, and continuous expansion of the disease to the breath, which is consistent with the ulcer enteritis characteristic, and in the case of ulcer ulcer ulcers and pebbles changes in the sectional distribution at the end of the rectum and in various parts of the colon, Cron disease is indicated.
Organization pathological characteristics also help to identify. The main manifestations of ulcer enteritis are chronic inflammation of the mucous membrane and the lower membrane, disarray of the cavity structure, sepsis formation of the cavity, reduction of the glass cell, etc. The pathology of Crohn ‘ s disease has changed to full-blown inflammation, with crack ulcer reaching deep under the mucous membranes and even the muscles, and non-cheese carcasses are characterized by carcasses that are not detected by all patients. If the pathology shows a mucous membrane chronic inflammation, an impossion with no flesh swollen swollen, more consideration is given to ulcer ulcer intestinal inflammation, and if there is a full-blown inflammation and non-cheese swollen swollen swollen swollen swollen, the Cron diagnosis is supported.
In addition, other diseases need to be identified. The intestinal nodules are manifested in the form of low-heat, sweat-throwing and inactivity of nodules, with lower intestinal cortex in the back-blind, ulcer ulcers in circular shape and pathologically visible cheesy as carcasses. The intestinal lymphoma can cause heat, wasting, abdominal pain, abdominal cortex, etc., with a wide variety of variations in the lower endoscopy, which can be diagnosed with tissue tests. Infective entericitis, such as bacterial dysentery, amiba dysentery, etc., usually has a clear history of infection, faeces are developed to detect pathogens, anti-infection treatment is effective, and endoscopy and pathologies differ from inflammatory intestinal diseases.
In general, the identification of inflammatory intestinal diseases requires a comprehensive analysis of the combination of clinical symptoms, endoscopy, tissue pathology and other relevant findings, in order to make an accurate distinction between ulcer and Cronn ‘ s diseases, or to exclude other similar diseases, with a view to developing precise individualized treatment programmes for patients and improving their prognosis and quality of life.
